Joint Department of Medical Imaging, University of Toronto, Ontario, Canada.
Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Abdom Radiol (NY). 2020 Aug;45(8):2603-2611. doi: 10.1007/s00261-020-02544-0.
To determine preferences of clinicians and surgeons regarding radiology reporting of liver observations in patients at risk for hepatocellular carcinoma (HCC).
Members of the American College of Radiology Liver Imaging and Data Reporting System (LI-RADS) Outreach & Education Group (30 members) as well as Society of Abdominal Radiology Disease-Focused Panel on HCC diagnosis (27 members) created and distributed an 18-question survey to clinicians and surgeons, with focus on preferences regarding radiology reporting of liver observations in patients. The survey questions were directed to physician demographics, current use of LI-RADS by their local radiologists, their opinions about current LI-RADS and potential improvements.
A total of 152 physicians responded, 66.4% (101/152) from North America, including 42 surgeons, 81 physicians and 29 interventional radiologists. Participants were predominantly from academic centers 83% (126/152), while 13.8% (21/152) worked in private/community centers and 3.2% (5/152) worked in a hybrid practice. Almost 90% (136/152) of participants preferred the use of LI-RADS (compared to nothing or other standardized reporting systems; OPTN and AASLD) to communicate liver-related observations. However, only 28.5% (43/152) of participants input was sought at the time of implementing LI-RADS in their institutions. Fifty-eight percent (88/152) of all participants found standardized LI-RADS management recommendations in radiology reports to be clinically helpful. However, a subgroup analysis of surgeons in academic centers showed that 61.8% (21/34) prefer not to receive standardized LI-RADS recommendations.
Most participants preferred the use LI-RADS in reporting CT and MRI examination. When considering inclusion of management recommendations, radiologists should consult with their referring physicians, as preference may differ.
确定临床医生和外科医生对肝癌(HCC)高危患者肝脏观察的放射学报告的偏好。
美国放射学院肝脏成像和数据报告系统(LI-RADS)推广与教育小组的 30 名成员以及腹部放射学会 HCC 诊断重点小组的 27 名成员共同创建并分发了一份针对临床医生和外科医生的 18 个问题的调查,重点关注对 HCC 高危患者肝脏观察的放射学报告的偏好。调查问题针对医生的人口统计学特征、当地放射科医生当前对 LI-RADS 的使用情况、他们对当前 LI-RADS 的看法以及潜在的改进。
共有 152 名医生做出回应,其中 66.4%(101/152)来自北美,包括 42 名外科医生、81 名内科医生和 29 名介入放射科医生。参与者主要来自学术中心(126/152),占 83%,而 13.8%(21/152)在私人/社区中心工作,3.2%(5/152)在混合实践中工作。近 90%(136/152)的参与者更喜欢使用 LI-RADS(与无报告或其他标准化报告系统相比;器官获取和移植网络[OPTN]和美国肝病研究协会[AASLD])来传达与肝脏相关的观察结果。然而,只有 28.5%(43/152)的参与者在其机构实施 LI-RADS 时被征求意见。所有参与者中有 58%(88/152)发现放射学报告中标准化的 LI-RADS 管理建议具有临床帮助。然而,对学术中心外科医生的亚组分析表明,61.8%(21/34)的人不希望收到标准化的 LI-RADS 建议。
大多数参与者更喜欢在报告 CT 和 MRI 检查时使用 LI-RADS。在考虑纳入管理建议时,放射科医生应咨询其转诊医生,因为偏好可能不同。